rs41312104

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001034853.2(RPGR):​c.1598C>T​(p.Thr533Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0235 in 1,207,527 control chromosomes in the GnomAD database, including 288 homozygotes. There are 8,907 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T533A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.020 ( 38 hom., 621 hem., cov: 22)
Exomes 𝑓: 0.024 ( 250 hom. 8286 hem. )

Consequence

RPGR
NM_001034853.2 missense

Scores

16

Clinical Significance

Benign reviewed by expert panel B:10O:1

Conservation

PhyloP100: -0.0500

Publications

7 publications found
Variant links:
Genes affected
RPGR (HGNC:10295): (retinitis pigmentosa GTPase regulator) This gene encodes a protein with a series of six RCC1-like domains (RLDs), characteristic of the highly conserved guanine nucleotide exchange factors. The encoded protein is found in the Golgi body and interacts with RPGRIP1. This protein localizes to the outer segment of rod photoreceptors and is essential for their viability. Mutations in this gene have been associated with X-linked retinitis pigmentosa (XLRP). Multiple alternatively spliced transcript variants that encode different isoforms of this gene have been reported, but the full-length natures of only some have been determined. [provided by RefSeq, Dec 2008]
RPGR Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 3
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • RPGR-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • primary ciliary dyskinesia-retinitis pigmentosa syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • macular degeneration, X-linked atrophic
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017929971).
BP6
Variant X-38288016-G-A is Benign according to our data. Variant chrX-38288016-G-A is described in ClinVar as Benign. ClinVar VariationId is 92854.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0199 (2225/111643) while in subpopulation NFE AF = 0.029 (1540/53134). AF 95% confidence interval is 0.0278. There are 38 homozygotes in GnomAd4. There are 621 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High AC in GnomAd4 at 2225 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPGRNM_001034853.2 linkc.1598C>T p.Thr533Met missense_variant Exon 14 of 15 ENST00000645032.1 NP_001030025.1 Q92834-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPGRENST00000645032.1 linkc.1598C>T p.Thr533Met missense_variant Exon 14 of 15 NM_001034853.2 ENSP00000495537.1 Q92834-6
ENSG00000250349ENST00000465127.1 linkc.172-378105G>A intron_variant Intron 3 of 8 5 ENSP00000417050.1 B4E171

Frequencies

GnomAD3 genomes
AF:
0.0199
AC:
2225
AN:
111591
Hom.:
38
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00365
Gnomad AMI
AF:
0.207
Gnomad AMR
AF:
0.0160
Gnomad ASJ
AF:
0.0439
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00150
Gnomad FIN
AF:
0.0192
Gnomad MID
AF:
0.0420
Gnomad NFE
AF:
0.0290
Gnomad OTH
AF:
0.0153
GnomAD2 exomes
AF:
0.0189
AC:
3446
AN:
182733
AF XY:
0.0182
show subpopulations
Gnomad AFR exome
AF:
0.00411
Gnomad AMR exome
AF:
0.0126
Gnomad ASJ exome
AF:
0.0439
Gnomad EAS exome
AF:
0.0000722
Gnomad FIN exome
AF:
0.0196
Gnomad NFE exome
AF:
0.0272
Gnomad OTH exome
AF:
0.0288
GnomAD4 exome
AF:
0.0238
AC:
26108
AN:
1095884
Hom.:
250
Cov.:
30
AF XY:
0.0229
AC XY:
8286
AN XY:
362224
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00379
AC:
100
AN:
26368
American (AMR)
AF:
0.0132
AC:
465
AN:
35190
Ashkenazi Jewish (ASJ)
AF:
0.0410
AC:
794
AN:
19349
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30194
South Asian (SAS)
AF:
0.00346
AC:
187
AN:
54108
European-Finnish (FIN)
AF:
0.0214
AC:
864
AN:
40422
Middle Eastern (MID)
AF:
0.0396
AC:
163
AN:
4120
European-Non Finnish (NFE)
AF:
0.0268
AC:
22482
AN:
840105
Other (OTH)
AF:
0.0229
AC:
1052
AN:
46028
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.399
Heterozygous variant carriers
0
835
1670
2504
3339
4174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
824
1648
2472
3296
4120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0199
AC:
2225
AN:
111643
Hom.:
38
Cov.:
22
AF XY:
0.0183
AC XY:
621
AN XY:
33895
show subpopulations
African (AFR)
AF:
0.00364
AC:
112
AN:
30783
American (AMR)
AF:
0.0160
AC:
168
AN:
10497
Ashkenazi Jewish (ASJ)
AF:
0.0439
AC:
116
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3584
South Asian (SAS)
AF:
0.00150
AC:
4
AN:
2663
European-Finnish (FIN)
AF:
0.0192
AC:
114
AN:
5927
Middle Eastern (MID)
AF:
0.0413
AC:
9
AN:
218
European-Non Finnish (NFE)
AF:
0.0290
AC:
1540
AN:
53134
Other (OTH)
AF:
0.0151
AC:
23
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
85
170
254
339
424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0263
Hom.:
1230
Bravo
AF:
0.0190
TwinsUK
AF:
0.0264
AC:
98
ALSPAC
AF:
0.0322
AC:
93
ESP6500AA
AF:
0.00339
AC:
13
ESP6500EA
AF:
0.0293
AC:
197
ExAC
AF:
0.0195
AC:
2362
EpiCase
AF:
0.0281
EpiControl
AF:
0.0287

ClinVar

Significance: Benign
Submissions summary: Benign:10Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:4
Jan 13, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Thr533Met in exon 14 of RPGR: This variant is not expected to have clinical si gnificance because it has been identified in 2.9% (197/6728) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs41312104). -

Oct 03, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 11, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3Other:1
Jul 18, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 23, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 26, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RPGR-related retinopathy Benign:1
Aug 03, 2025
ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

NM_001034853.2(RPGR):c.1598C>T (p.Thr533Met) is a missense variant predicted to cause substitution of threonine by methionine at amino acid 533. This variant is present in gnomAD v.4.1.0 at a frequency of 0.02249 among hemizygous individuals, with 8,907 variant alleles / 396,119 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). This variant has been observed in more than 6 individuals with no features or family history of RPGR-related RP, a condition with full penetrance at an early age (PMIDs: 10482958, 11992260, 10980543, 19377476). However, it is not clear whether these individuals underwent a complete visual examination, so BS2 was not met. The computational predictor REVEL gives a score of 0.015, which is below the ClinGen X-linked IRD VCEP threshold of < 0.016 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.03, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4_Strong). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; BA1 and BP4_Strong. (date of approval 05/16/2025). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.88
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.015
DANN
Benign
0.78
DEOGEN2
Benign
0.021
.;.;T;.;.;.
FATHMM_MKL
Benign
0.0036
N
LIST_S2
Benign
0.48
.;T;T;T;.;T
MetaRNN
Benign
0.0018
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.79
N;N;N;.;N;N
PhyloP100
-0.050
PrimateAI
Benign
0.34
T
PROVEAN
Benign
1.1
N;.;N;.;.;N
REVEL
Benign
0.015
Sift
Benign
0.16
T;.;T;.;.;.
Sift4G
Benign
0.14
T;.;T;.;.;T
Polyphen
0.27
B;B;.;.;.;.
Vest4
0.061
MPC
0.022
ClinPred
0.0098
T
GERP RS
-3.7
Varity_R
0.012
gMVP
0.061
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41312104; hg19: chrX-38147269; API